• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UNK HAKIM PROGRAMMABLE VALVE; SHUNT, CENTRAL NERVOUS SYSTEM & COMPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UNK HAKIM PROGRAMMABLE VALVE; SHUNT, CENTRAL NERVOUS SYSTEM & COMPS Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Erosion (1750)
Event Date 01/12/2007
Event Type  Injury  
Manufacturer Narrative
Udi: unknown product code.Complaint sample was not returned to codman and no lot number information has been provided; therefore, an evaluation of the device could not be performed and manufacturing records could not be reviewed.The cause(s) of the difficulty reported by the customer could not be determined.At the present time this complaint is closed.Device not available.
 
Event Description
In the literature article ¿laparoscopic peritoneal catheter placement: results of a new method in 111 patients.¿ published neurosurgery 61:ons-167¿ons-174, 2007 doi:10.1227/01.Neu.0000279990.80706.1f, it was reported that this (b)(6) female patient presented with nph (normal pressure hydrocephalus), and an unknown hakim programmable valve was implanted for treatment.Post implantation there was wound break down and the surgical site was revised although the device was not removed or replaced.Per the article: ¿although cerebrospinal fluid shunting remains one of the most common neurosurgical procedures, it is fraught with high infection, blockage, and reoperation rates.It has been estimated that the economic cost of ventriculoperitoneal shunting exceeds $1 billion annually.A new laparoscopic technique that eliminates abdominal incisions overlying shunt hardware was applied to 111 patients requiring ventriculoperitoneal shunts in an effort to decrease the morbidity associated with shunting¿one hundred eleven patients underwent 113 laparoscopic ventriculoperitoneal shunt surgeries between february 2003 and december 2004.The average follow up period was 21.7 months (range, 12¿34 mo).Nearly half of the patients (49%) were discharged the next morning and the majority (81%) was discharged within 2 days of surgery.Overall, 15 patients experienced complications requiring reoperation (13.5%) with a 1-year shunt survival rate of 91%.One patient (0.9%) acquired a new shunt infection, whereas two patients (1.8%) developed recurrence from a previous shunt infection.There were no abdominal incision-related complications¿this simplified laparoscopic shunt placement technique, which requires no overlying abdominal incisions, can be performed quickly with high shunt survivability and low infection rates.Furthermore, the laparoscopic method has the advantage of fast recovery time, elimination of preperitoneal or misplaced catheters, and decreased abdominal incision morbidity.The procedure can be performed by either a multidisciplinary team or entirely by neurosurgeons¿.All patients had codman programmable valve systems placed with codman bactiseal silicone ventricular and distal catheters (codman, raynham, ma).Patients with nph had valves set at 140 mmhg, whereas others had varied valve pressure settings depending on their diagnosis or valve pressure history.¿ at the time of complaint entry there is no catalogue or lot number information available.This submission is related to a literature article discovered in an effort to support the cer submission process, as such, the associated time frame of event dates includes but is not limited to 20 years.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK HAKIM PROGRAMMABLE VALVE
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM & COMPS
Manufacturer Contact
james kenney
325 paramount drive
raynham, MA 02767
5088282726
MDR Report Key7099491
MDR Text Key94284880
Report Number1226348-2017-10942
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/08/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received11/15/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
-
-